Meredith Ambrose.

Simbartl, M.S., D. Scott Obrosky, M.S., Marta L. Render, M.D., Ron W. Freyberg, M.S., John A. Jernigan, M.D., Robert R. Muder, M.D., LaToya J. Miller, M.P.H., and Gary A. Roselle, M.D.: Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections Methicillin-resistant Staphylococcus aureus infections certainly are a issue in the United States1 and elsewhere. MRSA is among the most common factors behind ventilator-associated pneumonia, bloodstream infections connected with central venous catheters, and surgical-site infections.4 Based on the success of the pilot study in the VA Pittsburgh Healthcare System, and recognizing the significance of preventing MRSA infections for all veterans, the Veterans Health Administration , a division of the Department of Veterans Affairs, issued a directive beginning in March 2007 also to implement the bundle in every remaining acute care products by October 1, 2007.AMP does concur that some tests may need greater scrutiny and could warrant additional regulatory review. An LDT that may require further regulation is one that: Runs on the non-transparent algorithm with multiple markers that can’t be elucidated by other test developers, or Depends on technology that is not replicated by multiple laboratories, and for which a false result would cause significant mortality or morbidity, or a false result could possess a widespread adverse effect for public health Nevertheless, Dr.